Nanobody-Enhanced Targeting of AAV Gene Therapy Vectors

Anna Marei Eichhoff , Kathleen Börner (1) , Birte Albrecht , Waldemar Schäfer , Natalie Baum , Friedrich Haag (2) , Jakob Körbelin , Martin Trepel , Ingke Braren (3) , Dirk Grimm (1) , Sahil Adriouch (4) , Friedrich Koch-Nolte (2)

1 Cluster of Excellence CellNetworks - Department of Infectious Diseases/Virology [Heidelberg, Germany]
2 Institute for Immunology
3 UKE - Universitaetsklinikum Hamburg-Eppendorf = University Medical Center Hamburg-Eppendorf [Hamburg]
4 Physiopathologie et biothérapies des maladies inflammatoires et autoimmunes

Domains: Life Sciences [q-bio]; Immunology; Life Sciences [q-bio]; Biochemistry, Molecular Biology; Life Sciences [q-bio]; Biotechnology; Life Sciences [q-bio]; Immunology; Vaccinology; Life Sciences [q-bio]; Immunology; Immunotherapy; Life Sciences [q-bio]; Immunology; Adaptive immunology; Life Sciences [q-bio]; Bioengineering

Anna Marei Eichhoff, Kathleen Börner, Birte Albrecht, Waldemar Schäfer, Natalie Baum, et al.. Nanobody-Enhanced Targeting of AAV Gene Therapy Vectors. Molecular Therapy - Methods and Clinical Development, 2019, 15, pp.211-220. ⟨10.1016/j.omtm.2019.09.003⟩. ⟨hal-02376242⟩